Your browser doesn't support javascript.
loading
Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol.
Di Giuseppe, Luis A; Buela, Gabriela; Zacariaz Hereter, Johana B; Terrasa, Sergio A; Garfi, Leonardo G; Soriano, Enrique R.
Affiliation
  • Di Giuseppe LA; Department of Pharmacology-Toxicology, Instituto Universitario, Escuela de Medicina, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. Electronic address: luis.digiuseppe@hospitalitaliano.org.ar.
  • Buela G; Family and Community Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Zacariaz Hereter JB; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Terrasa SA; Department of Research, Instituto Universitario, Escuela de Medicina del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Department of Public Health, Instituto Universitario, Escuela de Medicina Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Garfi LG; Department of Public Health, Instituto Universitario, Escuela de Medicina Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Soriano ER; Department of Public Health, Instituto Universitario, Escuela de Medicina Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Value Health Reg Issues ; 21: 201-204, 2020 May.
Article in En | MEDLINE | ID: mdl-32199257

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patients / Arthritis, Rheumatoid / Risk Sharing, Financial / Certolizumab Pegol Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Value Health Reg Issues Year: 2020 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patients / Arthritis, Rheumatoid / Risk Sharing, Financial / Certolizumab Pegol Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Value Health Reg Issues Year: 2020 Document type: Article Country of publication: United States